Cargando…

Efficacy and Safety of Rituximab in Central Nervous System Demyelinating Disorders

BACKGROUND: Rituximab, an anti-CD20 monoclonal antibody, has been used worldwide as an off-label therapy in patients with multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD). OBJECTIVE: The aim of the present study was to evaluate the efficacy and safety of rituximab in centr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patil, Varsha A., Kamat, Saurabh N., Lalkaka, Jamshed A., Singhal, Bhim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8680882/ https://www.ncbi.nlm.nih.gov/pubmed/35002132 http://dx.doi.org/10.4103/aian.AIAN_167_21

Ejemplares similares

Demyelinating Disorders of the Central Nervous System
por: Pirko, Istvan, et al.
Publicado: (2007)

Central nervous system inflammatory demyelinating disorders of childhood
por: Kamate, Mahesh, et al.
Publicado: (2010)

Comment on: Central nervous system inflammatory demyelinating disorders of childhood
por: Radhakrishna, H.
Publicado: (2011)

HCV-Related Central and Peripheral Nervous System Demyelinating Disorders
por: Mariotto, Sara, et al.
Publicado: (2014)

Acquired demyelinating disorders of central nervous system: A pediatric cohort
por: Gulati, Sheffali, et al.
Publicado: (2015)

Inflammatory demyelinating diseases of the central nervous system
por: Höftberger, Romana, et al.
Publicado: (2018)

Rituximab in Neuromyelitis Optica Spectrum Disorders: Our Experience
por: Jade, Jui Dilip, et al.
Publicado: (2017)

Comparison of MRI Lesion Evolution in Different Central Nervous System Demyelinating Disorders
por: Sechi, Elia, et al.
Publicado: (2021)

Secondary Central Nervous System Demyelinating Disorders in the Elderly: A Narrative Review
por: Bakirtzis, Christos, et al.
Publicado: (2023)

The role of interleukin-6 in central nervous system demyelination
por: Petković, Filip, et al.
Publicado: (2016)

Biomarkers in Rare Demyelinating Disease of the Central Nervous System
por: Boziki, Marina, et al.
Publicado: (2020)

The Role of Extracellular Vesicles in Demyelination of the Central Nervous System
por: López-Guerrero, José Antonio, et al.
Publicado: (2020)

Tamoxifen accelerates the repair of demyelinated lesions in the central nervous system
por: Gonzalez, Ginez A., et al.
Publicado: (2016)

The Role of Rituximab in Primary Central Nervous System Lymphoma
por: Bromberg, Jacoline E. C., et al.
Publicado: (2020)

Citation classics in central nervous system inflammatory demyelinating disease
por: Kim, Jee‐Eun, et al.
Publicado: (2017)

Coronavirus infects and causes demyelination in primate central nervous system
por: Murray, Ronald S., et al.
Publicado: (1992)

Demyelinating Disease of the Central Nervous System Concurrent With COVID-19
por: Karsidag, Sibel, et al.
Publicado: (2021)

Models of autoimmune demyelination in the central nervous system: on the way to translational medicine
por: Linker, Ralf A, et al.
Publicado: (2009)

Central nervous system Listeria monocytogenes infection mimicking central nervous system idiopathic inflammatory demyelinating disease
por: Xu, Rui, et al.
Publicado: (2019)

Interleukin-6, S-Nitrosothiols, and Neurodegeneration in Different Central Nervous System Demyelinating Disorders: Is There a Relationship?
por: Fominykh, Vera, et al.
Publicado: (2018)

Clinical and Radiological Profiles, Treatment, and Outcome of Pediatric Acquired Demyelinating Disorders of Central Nervous System
por: Gowda, Vykuntaraju K., et al.
Publicado: (2019)

The association between cognition and gait disturbance in central nervous system demyelinating disorder with mild disability
por: Chang, Min Cheol, et al.
Publicado: (2023)

Plasma exchange in inflammatory demyelinating disorders of the central nervous system: reasonable use in the clinical practice
por: Queiroz, André Luiz Guimarães de, et al.
Publicado: (2023)

The Role of Rituximab in the Treatment of Primary Central Nervous System Lymphoma
por: Van Dijck, Ruben, et al.
Publicado: (2021)

The crucial role of Erk2 in demyelinating inflammation in the central nervous system
por: Okazaki, Rentaro, et al.
Publicado: (2016)

Imaging Central Nervous System Demyelination and Remyelination by Positron-Emission Tomography
por: Bodini, Benedetta, et al.
Publicado: (2016)

Insights into Initial Demyelinating Episodes of Central Nervous System during Puerperium
por: Wu, Qian, et al.
Publicado: (2017)

Pregnancy-Related Immune Changes and Demyelinating Diseases of the Central Nervous System
por: Qiu, Ke, et al.
Publicado: (2019)

Renal cell carcinoma with central nervous system demyelination caused by nivolumab
por: Oka, Toshiki, et al.
Publicado: (2020)

Central nervous system demyelinating diseases: glial cells at the hub of pathology
por: Coutinho Costa, Vinicius Gabriel, et al.
Publicado: (2023)

Characteristics of hypersomnia due to inflammatory demyelinating diseases of the central nervous system
por: Ishido, Hideaki, et al.
Publicado: (2023)

Clinical efficacy of belimumab in central nervous system demyelinating syndromes with systemic lupus erythematosus: A case series
por: Liu, Ya, et al.
Publicado: (2023)

Mesenchymal Stem Cell-Derived Extracellular Vesicles and Their Therapeutic Use in Central Nervous System Demyelinating Disorders
por: Allegretta, Caterina, et al.
Publicado: (2022)

Neuromyelitis optica-IgG testing in an Indian cohort with neuromyelitis optica and related demyelinating disorders: Our experience
por: Unni, Narayanan, et al.
Publicado: (2013)

Demyelinating and Thrombotic Diseases of the Central Nervous System: Common Pathogenic and Triggering Factors
por: Koudriavtseva, Tatiana, et al.
Publicado: (2015)

A comparative study of experimental mouse models of central nervous system demyelination
por: Dumitrascu, Oana M., et al.
Publicado: (2014)

Vitamin D Supplementation in Central Nervous System Demyelinating Disease—Enough Is Enough
por: Häusler, Darius, et al.
Publicado: (2019)

Chinese Guidelines for the Diagnosis and Management of Tumefactive Demyelinating Lesions of Central Nervous System
Publicado: (2017)

Central nervous system Cryptococcoma mimicking demyelinating disease: a case report
por: Wei, Jie, et al.
Publicado: (2020)

Histopathological variation in the demyelinating sentinel lesion of primary central nervous system lymphoma
por: Bajagain, Madan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ts03oe8pkej60t35a2hfc20s3e